about
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cellsPotent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaAssociation of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)".KRAS and BRAF genotyping of synchronous colorectal carcinomas.Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung.EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: a case report.Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma.Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement.Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene.Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1.Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis.Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.Follicular-derived neoplasms: morphometric and genetic differences.ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction.Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1.BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas.Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.Incidental versus clinically evident thyroid cancer: a 5-year follow-up studyMolecular testing in the diagnosis of differentiated thyroid carcinomasApplications of tissue microarray technology in immunohistochemistry: A study on c-kit expression in small cell lung cancerMeningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case reportGalectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens
P50
Q24519206-B8EBCFF7-C237-48E8-8D8E-C3F811FC9731Q24669934-9CA2A25C-D6B7-4231-93D0-519B7A7F21D7Q33296950-8FF19976-BB99-4ECA-A224-1F20C5FE17C0Q33782114-152B0F2C-BA4B-41D2-9221-41B941F2EE3FQ34543110-04E0EC57-EE48-4315-B1E9-F876B7F167BAQ36066994-4541057E-1E63-400E-99F0-668D6337C5DAQ36431628-A384897B-C759-487C-9DB8-15CB8A19000AQ38692526-8E802C8A-3F62-4060-91AE-76A43D91A46CQ38932624-3893B8DF-87A0-43A5-BE06-1086EF7CDCC5Q39106511-80D3D80F-359F-4086-9190-13BE92A7CD16Q39195364-F121CC5C-F5AC-4A4C-AEBB-237B3B56D3F6Q39377125-DF24005A-7F45-410A-BB08-A7524B2FE815Q39420886-A8FFBCAC-F21F-48F4-9910-6C685608EF4BQ39951413-E17A8314-EE0A-4754-B588-4DBD0A4F9EB8Q40125465-44ACEC43-5DFF-42F4-AB91-F2215211ABEEQ40284970-B73867C1-4314-40BD-9A30-F8D035AC810DQ40755317-49BCFCF6-15CD-4D25-9570-74DBF0D4A094Q40857012-38C03EB6-6E94-4104-99E8-3A7083CD9E79Q40948868-02842E01-8C8A-4675-9A9B-67FA9277DF8BQ41076810-DAC3A527-94B6-452F-9520-CDB5A0102E3FQ42805359-4E485CDA-64AC-40D3-8791-E0514D2FBE03Q42970251-8BE1FD0C-4A57-4349-9AF6-97173945CF49Q44995693-6F5D69CD-E090-4041-B559-4F7E51987395Q45161417-E04CEE6A-9028-4D0B-92F0-FA08EF951432Q45967709-0F166402-1B94-43FC-A43F-ED1CDE8F583AQ46144361-A9D99F4E-A94B-46D0-8D84-2BACCD0AAB40Q46373846-047E3AE4-56E9-46B4-9105-1E52185DCC57Q47254002-A5F8CDF6-A6F6-40F1-8FCD-A1217A684B3CQ49665971-BBB7DA24-0626-4B29-951D-2763C6014DF2Q51633399-76C15031-66C9-4C24-B744-B1E5C92488A1Q52970878-4EB07A8C-6CD5-432A-B3E5-D547B49CB194Q53295360-0832D625-B568-4952-A03F-8B6070E8C1CDQ54345945-64B47350-F134-4DB2-86A1-929C1D7495D9Q54561530-DF784E70-7886-4ECC-A9AD-8EBAA63FE940Q54655522-3876F835-2E3E-47C5-8ABA-ADF9B234D1DBQ57643470-C9394A50-E6FA-4674-B22E-94EE84329585Q58805430-356A19D5-11DC-4154-B01B-9C07C909AEBAQ59219302-9942295A-5BCB-4EF8-9F00-4C55E80AF44DQ59219336-9DF75A1E-EFD3-4520-B91C-D0AA8AB14888Q59219355-4C95E971-6FE7-4407-BAD0-F2084C497EED
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Riccardo Giannini
@ast
Riccardo Giannini
@en
Riccardo Giannini
@es
Riccardo Giannini
@nl
Riccardo Giannini
@sl
type
label
Riccardo Giannini
@ast
Riccardo Giannini
@en
Riccardo Giannini
@es
Riccardo Giannini
@nl
Riccardo Giannini
@sl
prefLabel
Riccardo Giannini
@ast
Riccardo Giannini
@en
Riccardo Giannini
@es
Riccardo Giannini
@nl
Riccardo Giannini
@sl
P1053
K-4223-2013
P106
P1153
7005537311
P21
P31
P3829
P496
0000-0001-9740-0219